Transforming Our Operating Model to Accelerate Growth and Unlock Productivity

Transforming Our Operating Model to Accelerate Growth and Unlock Productivity

Earlier today, at Avantor’s 2023 Investor Day event, I shared how we’re transforming our business to drive growth and accelerate innovation. In January, we will transition from three geographic segments to two business segments anchored in our customers’ laboratory and production needs. Over the past decade, we have built robust capabilities supporting our customers from discovery to delivery at a global scale, and this new operating model is a natural evolution that will advance our growth strategy. You can read more about our transformation here.

What is changing: This new model sharpens our focus on our customers’ research and production while aligning complementary capabilities and processes within Avantor to unlock additional efficiencies.

Randy Stone will lead our Lab Solutions segment, Benoit Gourdier will head our Bioscience Production business, and Jim Bramwell will lead our sales organization in the Americas and Europe. This new operating structure builds on the strength of our market position and will create value for customers and shareholders.

What’s not changing: our dedication to accelerating customer innovation throughout the entire scientific journey, from discovery to delivery.

·?????? In our Laboratory Solutions segment, we’re already a partner of choice and deeply engaged in our customers’ research workflows, from leaders in the biotech and pharmaceutical industry to world-renowned academic and medical institutions.

·?????? Our Bioscience Production segment is well-known for its high-purity custom materials, proprietary manufacturing and purification technologies, global quality system and deep regulatory expertise. Our teams will continue to support customers in the bioprocessing, healthcare, and advanced technologies sector that operate in a highly technical, highly regulated production environment.

There’s never been a more exciting time to be part of the scientific community. Avantor is proud to have supported some of the most important scientific discoveries and advancements of the 21st century. We have the right operating model, the right team, and the right strategy to successfully enable the science of today and tomorrow. I'm excited about the next chapter of our story.

#AvantorSetsScienceInMotion

Emily Collins

Communications executive | Brand building | Reputation & issues management | High performing teams

11 个月

Congrats, Michael. Excited for this chapter in Avantor’s evolution!

回复
Sebastian Kertzscher

Head of application test lab bei Ritter GmbH

11 个月

I'm looking forward to the new model. I'm keeping my fingers crossed for us

Jeff Chaponick

CEO at MAC Diversity Recruiters

11 个月
回复
Josef Zihlmann

#LabMarket #LifeScienceTools #LabInstruments #LabConsumables #LabServices #DrugDevelopment #bulk: Quarterly data, accurate modeling, funding, customers, persona, segmentation, behavior, trends, products, opportunities.

11 个月

Finally! Congratulations to this bold move. All the best.

回复
Stan Nelson

Senior Director, Global Strategic Accounts Leader at Thermo Fisher Scientific, Pharma Services Group - (PSG)

11 个月

Congrats, Jim and the rest of the leaders impacted by this change.

回复

要查看或添加评论,请登录

社区洞察

其他会员也浏览了